Table 1.
Characteristics of enrolled patients from CCCG-ALL-2015 cohort
| Characteristics | Group | No. patients (%) |
|---|---|---|
| Age (years) | ≥1, <10 | 291 (94.5) |
| <1, ≥10 | 17 (5.5) | |
| Gender | Female | 120 (39.0) |
| Male | 188 (61.0) | |
| FAB subtype | L1 | 66 (21.4) |
| L2 | 179 (58.1) | |
| L3 | 62 (20.1) | |
| Not determined | 1 (0.3) | |
| WBC (×109/L) | <50 | 257 (83.4) |
| ≥50 | 51 (16.6) | |
| Liver | Not detected | 115 (37.3) |
| <2 cm | 27 (8.8) | |
| ≥2, <5 cm | 139 (45.1) | |
| ≥5 cm | 27 (8.8) | |
| Spleen | Not detected | 172 (55.8) |
| <2 cm | 28 (9.1) | |
| ≥2, <5 cm | 84 (27.3) | |
| ≥5 cm | 24 (7.8) | |
| NCI Risk | Standard | 246 (79.9) |
| High | 62 (20.1) | |
| Risk stratified by CCCG-ALL-2015 | Low | 160 (51.9) |
| Intermediate | 146 (47.4) | |
| High | 2 (0.6) | |
| MRD19 | <0.01% | 107 (34.7) |
| ≥0.01% | 177 (57.5) | |
| MRD46 | <0.01% | 256 (83.1) |
| ≥0.01% | 52 (16.9) | |
| Relapse | No | 289 (93.8) |
| Yes | 19 (6.2) |